PFE Competitors
Pfizer Inc.
$29.39
-$0.06(-0.20%)
76
Overall
100
Value
83
Tech
47
Quality
Market Cap
$167.52B
Volume
48.32M
52W Range
$23.62 - $31.44
Target Price
$29.71
PFE competitors: MRK, JNJ, BMY, LLY, NVS. Pfizer Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
PFE Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| MRK Merck & Co., Inc. | $146.73 | $361.73B | $2.78 | 2.32% | 69 |
| JNJ Johnson & Johnson | $276.22 | $664.95B | $11.12 | 1.91% | 70 |
| BMY Bristol-Myers Squibb Company | $62.14 | $127.02B | $6.43 | 4.06% | 69 |
| LLY Eli Lilly and Company | $1354.00 | $1.27T | $35.35 | 0.49% | 69 |
| NVS Novartis AG | $162.55 | $310.17B | $9.04 | 2.94% | 68 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PFE | $29.39 | -0.2% | 48.32M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |